Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Regular paracetamol use could reduce ovarian cancer risk by almost a third

06.07.2006
Using paracetamol regularly could reduce the risk of ovarian cancer by almost a third, according to a detailed analysis in the July issue of British Journal of Clinical Pharmacology.

A research team from Athens University found that the risk fell by up to 30 per cent when they analysed the results of major studies carried out on more than 746,000 women over a six-year period.

4,405 of the women in the eight major studies – from the USA, UK and Denmark – had ovarian cancer.

The team looked at all studies covering paracetamol and ovarian cancer from 1966 to 2004. These were then scrutinised using sophisticated meta-analysis techniques.

“Meta-analysis involves doing a large amount of research into what has been published, summarising the results and combining them using statistical methods” explains lead researcher Dr Stefanos Bonovas from the Greek Ministry of Health. “Analysing a wide range studies can often throw new light on a problem and raise new research questions.

“In this case our analysis of eight major studies – covering nearly three-quarters of a million women - revealed a strong correlation between paracetamol use and a reduced risk of ovarian cancer.”

Seven of the studies looked at the links between paracetamol use and the incidence of ovarian cancer and the largest study looked at the link between paracetamol use and ovarian cancer deaths.

The researchers used a working definition of “regular use” as the highest frequency of drug use reported in the individual studies. This definition varied slightly between studies. In the largest study – which covered more than a third of the women diagnosed with ovarian cancer – it was defined as more than 30 tablets in the month before the study started.

“Ovarian cancer remains the most fatal gynaecological malignancy” says Dr Bonovas. “Its high mortality rate – mainly due to a combination of ineffective screening and the limited success of therapies for advanced disease - makes ovarian cancer a major health concern.

“Strategies that focus on prevention may therefore provide the most rational approach for reducing deaths from this form of cancer.

“Because paracetamol is so widely used, a link with a decreased risk of ovarian cancer could have important public health implications.”

The authors believe that further research among women with a high risk of developing ovarian cancer would provide further clues to the drug’s protective qualities.

“The risks of long-term paracetamol use - including liver and chronic kidney failure – may outweigh the potential benefits of preventing ovarian cancer in low-risk cases” concludes Dr Bonovas.

”However we believe that a randomised trial in women with a high risk of developing the disease might be appropriate. Further research is also needed into how this protective mechanism actually works.

The authors stress that they are not suggesting that women adopt this possible method of risk prevention at this stage.

“But we do feel that our study highlights the need for further research into this highly important link between a simple over-the-counter medicine and a very aggressive form of cancer” says Dr Bonovas.

Dr Bonovas works for the Department of Epidemiological Surveillance and Intervention at the Greek Ministry of Health’s Hellenic Centre for Infectious Diseases Control and carries out his research at Athens University.

This study was carried out in association with University researcher Dr Kalitsa Filioussi, under the supervision of Dr Nikolaos M Sitaras, Associate Professor of Medicine in the Department of Pharmacology.

Annette Whibley | alfa
Further information:
http://www.blackwellpublishing.com/bjcp

More articles from Health and Medicine:

nachricht One gene closer to regenerative therapy for muscular disorders
01.06.2017 | Cincinnati Children's Hospital Medical Center

nachricht The gut microbiota plays a key role in treatment with classic diabetes medication
01.06.2017 | University of Gothenburg

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Can we see monkeys from space? Emerging technologies to map biodiversity

An international team of scientists has proposed a new multi-disciplinary approach in which an array of new technologies will allow us to map biodiversity and the risks that wildlife is facing at the scale of whole landscapes. The findings are published in Nature Ecology and Evolution. This international research is led by the Kunming Institute of Zoology from China, University of East Anglia, University of Leicester and the Leibniz Institute for Zoo and Wildlife Research.

Using a combination of satellite and ground data, the team proposes that it is now possible to map biodiversity with an accuracy that has not been previously...

Im Focus: Climate satellite: Tracking methane with robust laser technology

Heatwaves in the Arctic, longer periods of vegetation in Europe, severe floods in West Africa – starting in 2021, scientists want to explore the emissions of the greenhouse gas methane with the German-French satellite MERLIN. This is made possible by a new robust laser system of the Fraunhofer Institute for Laser Technology ILT in Aachen, which achieves unprecedented measurement accuracy.

Methane is primarily the result of the decomposition of organic matter. The gas has a 25 times greater warming potential than carbon dioxide, but is not as...

Im Focus: How protons move through a fuel cell

Hydrogen is regarded as the energy source of the future: It is produced with solar power and can be used to generate heat and electricity in fuel cells. Empa researchers have now succeeded in decoding the movement of hydrogen ions in crystals – a key step towards more efficient energy conversion in the hydrogen industry of tomorrow.

As charge carriers, electrons and ions play the leading role in electrochemical energy storage devices and converters such as batteries and fuel cells. Proton...

Im Focus: A unique data centre for cosmological simulations

Scientists from the Excellence Cluster Universe at the Ludwig-Maximilians-Universität Munich have establised "Cosmowebportal", a unique data centre for cosmological simulations located at the Leibniz Supercomputing Centre (LRZ) of the Bavarian Academy of Sciences. The complete results of a series of large hydrodynamical cosmological simulations are available, with data volumes typically exceeding several hundred terabytes. Scientists worldwide can interactively explore these complex simulations via a web interface and directly access the results.

With current telescopes, scientists can observe our Universe’s galaxies and galaxy clusters and their distribution along an invisible cosmic web. From the...

Im Focus: Scientists develop molecular thermometer for contactless measurement using infrared light

Temperature measurements possible even on the smallest scale / Molecular ruby for use in material sciences, biology, and medicine

Chemists at Johannes Gutenberg University Mainz (JGU) in cooperation with researchers of the German Federal Institute for Materials Research and Testing (BAM)...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Plants are networkers

19.06.2017 | Event News

Digital Survival Training for Executives

13.06.2017 | Event News

Global Learning Council Summit 2017

13.06.2017 | Event News

 
Latest News

Quantum thermometer or optical refrigerator?

23.06.2017 | Physics and Astronomy

A 100-year-old physics problem has been solved at EPFL

23.06.2017 | Physics and Astronomy

Equipping form with function

23.06.2017 | Information Technology

VideoLinks
B2B-VideoLinks
More VideoLinks >>>